Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Neuland Laboratories Ltd. ( (IN:NEULANDLAB) ).
Neuland Laboratories Ltd. has informed the stock exchanges that a shareholder, identified under folio number 0005239, has reported the loss of a physical share certificate representing 100 shares. The company has received a request from this shareholder for issuance of a Letter of Confirmation in lieu of the lost certificate, in line with regulatory requirements, and has disclosed the matter for investor information and records.
The disclosure, made pursuant to Regulation 39(3) of the SEBI Listing Obligations and Disclosure Requirements, underscores the company’s compliance with procedural norms governing lost share certificates. While the event has no apparent impact on Neuland’s operations or financials, it reflects ongoing adherence to shareholder service protocols and transparency standards in its dealings with the exchanges and investors.
More about Neuland Laboratories Ltd.
Neuland Laboratories Ltd. is an India-based pharmaceutical company specializing in the development and manufacture of active pharmaceutical ingredients and related services for global generic and innovator drug markets. The company is listed on BSE and the National Stock Exchange of India under the symbol NEULANDLAB.
Average Trading Volume: 2,613
Technical Sentiment Signal: Hold
Current Market Cap: 164.5B INR
See more data about NEULANDLAB stock on TipRanks’ Stock Analysis page.